149 related articles for article (PubMed ID: 7879202)
21. Effects of different immunosuppressive protocols on renal hemodynamics of transplanted patients.
Abbud-Filho M; Barberato JB; Ramalho HJ; Yamazaki WM; Salgueiro MC; Silva ML; Ribeiro AC; Bezas AG
Transplant Proc; 1994 Oct; 26(5):2594-5. PubMed ID: 7940805
[No Abstract] [Full Text] [Related]
22. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
23. Effect of anti CD45 on different immunosuppressive regimes in renal transplantation.
Talbot D; Shenton BK; Bell A; White M; Glennon A; Manas D; Minford E; Rix D; Mathew A; Kumar A; Taylor RM
Transplant Proc; 1996 Dec; 28(6):3212-3. PubMed ID: 8999605
[No Abstract] [Full Text] [Related]
24. Effect of subclinical rejection on renal allograft histology and function at 6 months.
Rush D; Jeffery J; Trpkov K; Solez K; Gough J
Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
[No Abstract] [Full Text] [Related]
25. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
26. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
Beckingham IJ; Dennis MJ; Innes A; Burden RP; Morgan AG; Bishop MC
Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
[No Abstract] [Full Text] [Related]
27. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
[No Abstract] [Full Text] [Related]
28. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
29. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
[No Abstract] [Full Text] [Related]
30. Does low-dose allopurinol, with azathioprine, cyclosporin and prednisolone, improve renal transplant immunosuppression?
Chocair PR; Duley JA; Cameron JS; Arap S; Ianhez L; Sabbaga E; Simmonds HA
Adv Exp Med Biol; 1994; 370():205-8. PubMed ID: 7660891
[No Abstract] [Full Text] [Related]
31. Plasma endothelin level following kidney transplantation.
Kumano K; Masui N; Soh S; Mashimo S; Endo T
Transplant Proc; 1994 Aug; 26(4):2114-6. PubMed ID: 8066688
[No Abstract] [Full Text] [Related]
32. Diabetes mellitus after renal transplantation.
Basri N; Aman H; Adiku W; Baraqdar A; Bonatero I; Nezamuddin N
Transplant Proc; 1992 Oct; 24(5):1780-1. PubMed ID: 1412840
[No Abstract] [Full Text] [Related]
33. Addition of deoxyspergualin to standard triple immunosuppressive regimen in kidney transplantation.
Seki T; Tanda K; Chikaraishi T; Takeuchi I; Kanagawa K; Togashi M; Koyanagi T
Transplant Proc; 1996 Jun; 28(3):1352-3. PubMed ID: 8658690
[No Abstract] [Full Text] [Related]
34. Donor specific transfusion in kidney transplantation: effect of different immunosuppressive protocols on graft outcome.
Barbari A; Stephan A; Masri MA; Joubran N; Dagher O; Kamel G
Transplant Proc; 2001 Aug; 33(5):2787-8. PubMed ID: 11498161
[No Abstract] [Full Text] [Related]
35. The effect of cyclosporine and azathioprine on GFR and renal histopathology 12 to 24 months after renal transplantation.
Pedersen EB; Hansen HE; Olsen S
Transplant Proc; 1992 Feb; 24(1):309-10. PubMed ID: 1539289
[No Abstract] [Full Text] [Related]
36. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
[No Abstract] [Full Text] [Related]
37. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
Ebel H; Lange H
Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
[No Abstract] [Full Text] [Related]
38. Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
Gordge MP; Rylance PB; Neild GH
Clin Nephrol; 1992 Jan; 37(1):53-5. PubMed ID: 1541067
[No Abstract] [Full Text] [Related]
39. Clinical experience in transferring kidney transplant patients from sandimmun to sandimmun neoral--results after 6 months.
Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J
Transplant Proc; 1995 Oct; 27(5):2679-82. PubMed ID: 7482873
[No Abstract] [Full Text] [Related]
40. A randomized study comparing cyclosporine alone vs double and triple therapy in renal transplants. The Italian Multicentre Study Group for Renal Transplantation (SIMTRe).
Ponticelli C; Tarantino A; Segoloni GP; Cambi V; Rizzo G; Altieri P; Mastrangelo F; Castagneto M; Salvadori M; Valente U; Cossu M; Federico S; Pisani F; Montagnino G; Messina M; Arisi L; Carmellini M; Piredda G; Corbetta G
Transplant Proc; 1997; 29(1-2):290-1. PubMed ID: 9123000
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
